Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES
1,923 words·~9 min read·
/register/2006/09/01/06-7290A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4150-24-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities (NCBDDD) announces the following meeting. *Name:* National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE). *Times and Dates:* September 26, 2006, 8:30 a.m.-4:30 p.m.;
September 27, 2006, 8:30 a.m.-1 p.m. *Place:* Doubletree Atlanta Buckhead, 3342 Peachtree Road, NE., Atlanta, Georgia 30326, telephone 404 231-1234, fax 404 231-3112. *Status:* Open to the public, limited only by the space available. The meeting room accommodates approximately 80 people. *Purpose:* The Secretary is authorized by the Public Health Service Act, Section 399G, (42 U.S.C. Section 280f, as added by Public Law 105-392) to establish a National Task Force on Fetal Alcohol Syndrome
(FAS)and Fetal Alcohol Effect
(FAE)to:
(1)Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support FAS and FAE research, programs and surveillance; and
(2)to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE. *Matters to be Discussed:* Agenda items include: Overview of recent research on innovative approaches to help in identification and diagnosis of FAS and other alcohol-related neurodevelopmental disorders, update on Task Force report of evidence-based review of fetal alcohol spectrum disorders prevention strategies; updates from the Interagency Coordinating Committee on Fetal Alcohol Syndrome, the CDC and other Federal agencies, and liaison representatives; and scheduling of the next meeting. Agenda items are subject to change as priorities dictate. *For Further Information Contact:* Mary Kate Weber, M.P.H., Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E-86), Atlanta, Georgia 30333, telephone 404 498-3926, fax 404 498-3550. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 28, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6-14556 Filed 8-31-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention ICD-9-CM Coordination and Maintenance Committee Meeting The National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting. *Name:* ICD-9-CM Coordination and Maintenance Committee meeting. *Times and Dates:* 9 a.m.-5 p.m., September 28-29, 2006. *Place:* Centers for Medicare and Medicaid Services
(CMS)Auditorium, 7500 Security Boulevard, Baltimore, Maryland. *Status:* Open to the public. *Purpose:* The ICD-9-CM Coordination and Maintenance (C&M) Committee will hold its final meeting of the 2006 calendar year cycle on Thursday and Friday, September 28-29, 2006. The C&M meeting is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Ninth-Revision, Clinical Modification. *Matters To Be Discussed:* Tentative agenda items include: Abnormal cytology of vagina, Acquired absence of cervix/uterus, Acquired pure red cell aplasia, Antenatal screening, Avian
(bird)flu, Disorder/Disease of stomach index entries, E code for Fosamax and similar compounds, Fetal medicine, Harmful algae bloom, Hearing loss and speech language problems, History of stroke without residual deficits/TIA, Human Parvovirus, In vitro treatment status, Malignant ascites, Myotonic disorders, Osteonecrosis of jaw, drug induced, Personal history of sudden cardiac arrest (cardiac arrhythmia), Personal history of cervical dysplasia, Screening for HPV, Secondary Diabetes Mellitus (updated proposal), Septic embolism, TORCH infections, Total occlusion of peripheral vessel, Urinary risk factors, VIN and VAIN (Continuation), Addenda (diagnosis), Blood Brain Barrier, Coflex® interspinous stabilization device, Intracranial Pressure
(ICP)Monitoring and Oxygen Monitoring, Motion Preserving Technologies, NeuroThera TM : Non-invasive Ischemic Stroke Therapy, Pelvic Prolapse Repair, Rheos Baroreflex Activating System, Spy intraoperative fluorescence vascular angiography, Thoracoscopic procedures, TOPS TM Facet Replacement, Addenda (procedures), ICD-10-PCS. *Contact Person for Additional Information:* Amy Blum, Medical Systems Specialist, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782, e-mail *alb8@cdc.gov,* telephone 301-458-4106 (diagnosis), Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Blvd., Baltimore, Maryland 21244, e-mail *Marilu.Hue@cms.hhs.gov,* telephone 410-786-4510 (procedures). *Notice* : Because of increased security requirements CMS has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show an official form of picture I.D., (such as a drivers license), and sign-in at the security desk upon entering the building. Those who wish to attend a specific ICD-9-CM C&M meeting in the CMS auditorium must submit their name and organization for addition to the meeting visitor list. Those wishing to attend the September 28-29, 2006 meeting must submit their name and organization by September 25, 2006 for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Those who attended previous ICD-9-CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Register to attend the meeting on-line at: *http://cms.hhs.gov/events. * *Notice:* This is a public meeting. However, because of fire code requirements, should the number of attendants meet the capacity of the room, the meeting will be closed. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 28, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6-14557 Filed 8-31-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics
(NCHS)announces the following committee meeting. *Name:* Board of Scientific Counselors (BSC), NCHS. *Times and Dates:* 11 a.m.-5:30 p.m., September 14, 2006. *Place:* Hubert H. Humphrey Building, Room 705A, 200 Independence Avenue, SW., Washington, DC 20201. 8:30 a.m.-2 p.m., September 15, 2006. *Place:* NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782. *Status:* Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. *Purpose:* This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. *Matters To Be Discussed:* The agenda will include welcome remarks by the Director, NCHS; introductions of members and key NCHS staff; scientific presentations and discussions on the National Survey of Family Growth, implications of confidentiality requirements in natality and mortality vital statistics, and re-engineering the vital statistics system and role of health information technology; and an open session for comments from the public. Requests to make oral presentations should be submitted in writing to the contact person listed below by September 8, 2006. All requests must contain the name, address, telephone number, and organizational affiliation of the presenter. Written comments should not exceed five single-spaced typed pages in length and must be received by September 8, 2006. The agenda items are subject to change as priorities dictate. Due to programmatic matters, this **Federal Register** notice is being published on less than 15 calendar days notice to the public (41 CFR 102-3.150(b)). *Contact Person for More Information:* Virginia S. Cain, Ph.D., Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 7211, Hyattsville, Maryland 20782, telephone
(301)458-4500, fax
(301)458-4020. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 28, 2006. Alvin Hall, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E6-14629 Filed 8-31-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS-R-13 and CMS-10088] Agency Information Collection Activities: Proposed Collection; Comment Request AGENCY: Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services
(CMS)is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects:
(1)The necessity and utility of the proposed information collection for the proper performance of the agency's functions;
(2)the accuracy of the estimated burden;
(3)ways to enhance the quality, utility, and clarity of the information to be collected; and
(4)the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. *Type of Information Collection Request:* Revision of a currently approved collection. *Title of Information Collection:* Conditions of Coverage for Organ Procurement Organizations
(OPOs)and Supporting Regulations in 42 CFR 486.301-348. *Use:* Organ Procurement Organizations are required to submit accurate data to CMS through the Organ Procurement and Transplantation Network (OPTN). The data concerns the organ procurement activities, as well as various OPO business activities, including information on its designated service area; structure; various policies, procedures, and protocols; and its quality assessment and performance improvement
(QAPI)program. This information is necessary to assure maximum effectiveness in the procurement and distribution of organs. *Form Number:* CMS-R-13 (OMB#: 0938-0688. *Frequency:* Reporting—Every 4 years and as needed. *Affected Public:* Not-for-profit institutions. *Number of Respondents:* 58. *Total Annual Responses:* 58. *Total Annual Hours:* 21,427. 2. *Type of Information Collection Request:* Revision of a currently approved collection. *Title of Information Collection:* Notification of Fiscal Intermediaries
(FIs)and CMS of Co-located Medicare Providers and Supporting Regulations in 42 CFR 412.22 and 412.533. *Use:* Many long term care hospitals (LCTHs) are co-located with other Medicare providers (acute care hospitals, inpatient rehabilitation facilities, skilled nursing facilities, and psychiatric facilities), which leads to potential gaming of the Medicare system based on patient shifting. CMS is requiring LTCHs to notify fiscal intermediaries
(FIs)and CMS of co-located providers. In addition, CMS has established policies to limit payment abuse that will be based on FIs tracking patient movement among these co-located providers. *Form Number:* CMS-10088 (OMB#: 0938-0897. *Frequency:* Reporting—as needed. *Affected Public:* Business or other for profit and Not-for-profit institutions. *Number of Respondents:* 200. *Total Annual Responses:* 200. *Total Annual Hours:* 50. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS' Web site address at *http://www.cms.hhs.gov/PaperworkReductionActof1995,* or e-mail your request, including your address, phone number, OMB number, and CMS document identifier, to *Paperwork@cms.hhs.gov,* or call the Reports Clearance Office on
(410)786-1326. To be assured consideration, comments and recommendations for the proposed information collections must be received at the address below, no later than 5 p.m. on October 31, 2006. CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development—A, Attention: Melissa Musotto, Room C4-26-05, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. Dated: August 25, 2006. Michelle Shortt, Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 06-7290 Filed 8-31-06; 8:45 am]
Connectionstraces to 1
Traces to 1 document
5 references not yet in our index
- Pub. L. 92-463
- Pub. L. 105-392
- 41 CFR 102
- 42 CFR 486.301-348
- 42 CFR 412.22
Citation graph
cites case law
Notices
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Pub. L.Pub. L. 92-463
Pub. L.Pub. L. 105-392
Cite41 CFR 102
Cite42 CFR 486.301-348
Cite42 CFR 412.22
Cites 6Cited by 0 across 0 sources